http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
iCAD (ICAD) Granted Approval for Xoft Axxent Balloon Applicators by China Food & Drug Administration
-
Researchers to Present Clinical Data Supporting Use of Xoft System for Endometrial Cancer Treatment at American Association of Physicists in Medicine Annual Meeting & Exhibition
-
iCAD (ICAD) Reports Positive Study Results Comparing its eBx System to Mohs Surgery in Treatment of Early-stage NMSC Patients
-
iCAD announces positive study results comparing use of company’s Xoft® Axxent® Electronic Brachytherapy (eBx®) System® to Mohs surgery in treatment of early-stage non-melanoma skin cancer
-
First-Ever European Analysis of Electronic Brachytherapy Using the Xoft System for Endometrial and Cervical Cancer Treatment to be Presented at European Society for Radiotherapy & Oncology Meeting
-
iCAD Announces First Early-Stage Breast Cancer Patient Treated with Intraoperative Radiation Therapy Using the Xoft System at Monash Cancer Centre, a partnership between Peter MacCallum Cancer Centre
-
iCAD to Showcase Breakthrough Early-Stage Breast Cancer Treatment Utilizing the Xoft System at American Society of Breast Surgeons (ASBrS) Annual Meeting
-
Researchers to Present Updated Clinical Data on Intraoperative Radiation Therapy Using the Xoft System at American Brachytherapy Society (ABS) Annual Meeting
-
iCAD Announces More Than 3,000 Early-Stage Breast Cancer Patients Treated with Intraoperative Radiation Therapy Using the Xoft System
-
iCAD Showcases Targeted, Non-Surgical Non-Melanoma Skin Cancer Treatment at AAD 2017
-
First-Ever Analysis of Intraoperative Radiation Therapy with Xoft System as a Boost Prior to Whole Breast Radiation to be Presented at San Antonio Breast Cancer Symposium
-
iCAD to Present Positive Clinical Data Supporting Use of Xoft System for Early-Stage Breast Cancer and Nonmelanoma Skin Cancer at ASTRO 2016
-
iCAD (ICAD) Announces Treatment of First Patient in Europe with Xoft Axxent eBx System
-
First Cervical Cancer Patient Treated in Europe with the Xoft System at Hospital Universitario Miguel Servet in Spain
-
iCAD Showcases Latest Technology Supporting Use of Xoft System for Non-melanoma Skin Cancer Treatment at AAD 2016
-
iCAD Expands Use of the Xoft Electronic Brachytherapy System in Europe, Asia and Australia
-
Researchers to Present Updated Data Regarding Intraoperative Radiation Therapy with the Xoft System at San Antonio Breast Cancer Symposium
-
iCAD Reports Use Of Xoft® Axxent® Electronic Brachytherapy System In The Treatment Of More Than 15,000 Non-Melanoma Skin Cancer Lesions
-
iCAD's Xoft System Selected as a Popular Science Magazine "Best of What's New" Award Winner for 2015
-
Researchers to Present Up to 5-Year Positive Clinical Data Supporting Use of Xoft System for Early-Stage Breast Cancer and Nonmelanoma Skin Cancer at ASTRO 2015
-
iCAD Launches National Educational Program to Increase Awareness of the Effective Use of Electronic Brachytherapy for the Treatment of Nonmelanoma Skin Cancer
-
iCAD Announces Commercial Availability Of Cervical Applicator For Treatment Of Gynecological Cancers At American Association Of Physicists In Medicine Meeting
-
iCAD Launches Digital Customer Training Platform To Support Professional Education In Use Of Xoft System For Treatment Of Non-Melanoma Skin Cancer, Early-Stage Breast Cancer And Gynecological Cancers
-
First Hospital In Spain Adopts Xoft Electronic Brachytherapy System For The Treatment Of Early-Stage Breast Cancer, Non-Melanoma Skin Cancer And Gynecological Cancers
-
Positive Clinical Data for iCAD's Xoft System to be Highlighted at American Brachytherapy Society (ABS) Annual Meeting
-
iCAD To Present Positive Four-Year Data On Xoft® Axxent® Electronic Brachytherapy (eBx®) System® For Non-Melanoma Skin Cancer (NMSC)

